In his October 10, 2016
article “Why It’s Too Soon to Say that HIV has been Cured,”
Knvul Sheikh argues that recent headlines claiming that a British man has been
cured of HIV are misleading. This man was a participant in a clinical trial
involving a “shock and kill” regimen. The idea is to activate “resting” CD4
cells, which are reservoirs of HIV even when the virus is undetectable via
blood tests. This would activate the virus as well so that scientists can boost
the patient’s immune system to destroy the virus-carrying cells while they’re
vulnerable.
However, some scientists
have criticized these articles because the only way to know that a person is
truly HIV-free is to test many different tissues, rather than just running a
blood test, and repeat these tests. In the recent case, the patient was also on antiretroviral therapy, which also reduces the viral load to the point where it
is undetectable via blood tests. Therefore, it is unknown if this new therapy has a different
effect than that of antiretroviral therapy.
The British man is the
first participant to complete the regimen, and the trial is not expected to be
complete until 2018. Stephen Morse, an epidemiologist and director of the Center for Public Health Preparedness at
Columbia University warns that even if the trial is a complete success, the
results should be interpreted with caution. The researchers will need to follow
up on the patients for years to make sure that HIV is truly gone and to check
other tissues for the virus. Janet Siliciano, an infectious disease expert at Johns Hopkins
University, says that the results would need to be replicated in larger
studies and the treatment needs to at least meet current regimens in terms of safety and effectiveness.
Knvul Sheikh "Why It’s Too Soon to Say that HIV has been Cured." Popular Science. 2016 October 10. http://www.popsci.com/why-its-too-soon-to-say-hiv-has-been-cured
No comments:
Post a Comment